Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Case Reports in Oncology|March 29, 2021
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 CasesMayuko Ito, Yoshiya Horimoto, Ritsuko Sasaki, et al.
Surgical Case Reports|September 19, 2018
Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndromeRitsuko Sasaki, Yoshiya Horimoto, Ju Mizuno, et al.
Japanese Journal of Clinical Oncology|March 18, 2026
Reclassification of a BRCA2 variant, c.8487G > a (p.Gln2829Gln) located at 3' end of exon 19, from uncertain significance to likely pathogenic based on splicing alteration: a case reportRitsuko Sasaki, Hidetaka Eguchi, Sayaka Yoshioka, et al.
Anticancer Research|April 4, 2021
Molecular Characteristics of Lymphocyte-predominant Triple-negative Breast CancerRitsuko Sasaki, Yoshiya Horimoto, Yuka Yanai, et al.
Cancer Science|July 25, 2022
Involvement of kallikrein-PAR2-proinflammatory pathway in severe trastuzumab-induced cardiotoxicityRitsuko Sasaki, Nagomi Kurebayashi, Hidetaka Eguchi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 5, 2016
Randomized Comparison of Subcuticular Sutures Versus Staples for Skin Closure After Open Abdominal Surgery: a Multicenter Open-Label Randomized Controlled TrialKazuhiro Imamura, Kensuke Adachi, Ritsuko Sasaki, et al.
Juntendo Iji Zasshi = Juntendo Medical Journal|July 18, 2024
Lessons Learned in Practice with Li-Fraumeni Syndrome: LFS-Related Breast Cancer Treatment Strategy and Establishment of a Surveillance SystemRitsuko Sasaki, Yoshiya Horimoto, Harumi Saeki, et al.
Breast Cancer Research and Treatment|June 24, 2020
High FOXA1 protein expression might predict late recurrence in patients with estrogen-positive and HER2-negative breast cancerYoshiya Horimoto, Noriko Sasahara, Ritsuko Sasaki, et al.
Breast Cancer (Tokyo, Japan)|February 29, 2020
Neutrophil-to-lymphocyte ratio and histological type might predict clinical responses to eriburin-based treatment in patients with metastatic breast cancerMayu Myojin, Yoshiya Horimoto, Mayuko Ito, et al.
The American Journal of Surgical Pathology|June 14, 2019
Estrogen Receptor-positive Ductal Carcinoma In Situ Frequently Overexpresses HER2 Protein Without Gene AmplificationYoshiya Horimoto, Takako Terao, Yuko Tsutsumi, et al.
Pageof 2